KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Other Accumulated Expenses: 2016-2024

Historic Other Accumulated Expenses for Ionis Pharmaceuticals (IONS) over the last 9 years, with Dec 2024 value amounting to $19.5 million.

  • Ionis Pharmaceuticals' Other Accumulated Expenses rose 12.44% to $24.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.8 million, marking a year-over-year increase of 12.44%. This contributed to the annual value of $19.5 million for FY2024, which is 34.25% down from last year.
  • According to the latest figures from FY2024, Ionis Pharmaceuticals' Other Accumulated Expenses is $19.5 million, which was down 34.25% from $29.6 million recorded in FY2023.
  • In the past 5 years, Ionis Pharmaceuticals' Other Accumulated Expenses ranged from a high of $30.9 million in FY2020 and a low of $12.2 million during FY2022.
  • For the 3-year period, Ionis Pharmaceuticals' Other Accumulated Expenses averaged around $20.4 million, with its median value being $19.5 million (2024).
  • In the last 5 years, Ionis Pharmaceuticals' Other Accumulated Expenses tumbled by 60.10% in 2021 and then skyrocketed by 142.65% in 2023.
  • Yearly analysis of 5 years shows Ionis Pharmaceuticals' Other Accumulated Expenses stood at $30.9 million in 2020, then crashed by 60.10% to $12.3 million in 2021, then dropped by 0.95% to $12.2 million in 2022, then skyrocketed by 142.65% to $29.6 million in 2023, then tumbled by 34.25% to $19.5 million in 2024.